Not yet recruitingInterventionalPhase 1Last updated Aug 12, 2026

A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart

A Double-blind, Randomized, Placebo-controlled, Multiple-dose, Parallel Group Design Trial With Moxifloxacin as Positive Control in a Nested Crossover to Evaluate the Effects of Multiple Doses of Verducatib (BI 1291583) on Cardiac Safety Parameters in Healthy Male and Female Trial Participants

Overview

ClinicalTrials.gov ID: NCT07760246
Lead Sponsor: Boehringer IngelheimINDUSTRY
Brief Summary: The main objective of this trial is to evaluate the effects of verducatib in the range of therapeutic to supra-therapeutic exposures on the QT/QTc-interval and other ECG parameters
Study Type: Interventional

Secondary IDs

2026-525813-30-00Registry Identifier

CTIS

U1111-1335-9069Registry Identifier

WHO International Clinical Trials Registry Platform (ICTRP)

Status

Overall Status: Not yet recruiting
Start Date: Aug 17, 2026Estimated
Primary Completion Date: Dec 16, 2026Estimated
Completion Date: Dec 30, 2026Estimated

Study Record Dates

First Submitted: Aug 7, 2026
First Submitted that Met QC Criteria: Aug 7, 2026
First Posted: Aug 12, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 7, 2026
Last Update Posted: Aug 12, 2026Actual
Last Verified: Aug 2026

NCT06107036Completed

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

NCT03504982Completed

Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

NCT03934203Completed

This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)

NCT07513207Active, not recruiting

A Study in Healthy People to Test How Vicadrostat Affects the Heart

NCT06746402Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

NCT07422298Completed

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants